Literature DB >> 17306328

Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize.

Ewa Domanowska1, Wojciech Jozwicki, Jan Domaniewski, Ryszard Golda, Zdzislaw Skok, Halina Wiśniewska, Renata Sujkowska, Zbigniew Wolski, Grazyna Jozwicka.   

Abstract

Few published studies have addressed the correlation between multidirectional differentiation in muscle-invasive bladder cancer and its ability to metastasize. We demonstrated that histologic differentiation within a single tumor affects lymph node metastasis. We examined cystectomy specimens from 93 bladder tumors and 1085 lymph nodes. In this study, urothelial cell carcinomas (UCCs) with divergent differentiation, excluding pure divergent patterns such as squamous cell carcinoma and adenocarcinoma that tend toward a distinct biologic behavior, were subjected to histopathologic estimation. The positive lymph node ratio increased with the nonconventional differentiation number (NDN) within a tumor from 8.7% for an NDN of 0 (pure conventional UCCs) to 35.5% for an NDN of 2 or higher (mixed conventional and nonconventional [NC] UCCs showing >2 NC patterns). The positive lymph node number (PLN) was more than twice as high for an NDN of 3 or higher as compared with cases with an NDN of 0. Lymph node positivity (LP) was associated with the presence of micropapillary, lymphoma-like, plasmacytoid, giant cell, or clear cell-type tumors, and increasing PLN was associated with the presence of glandular, nested, lymphoma-like, plasmacytoid, or undifferentiated types in the primary tumor. By multivariate analysis, NDN status was determined to be an independent predictor of PLN (P = .032). Tumor stage had impact on LP (P = .002); however, in cases with a PLN of 4 or higher, the NDN became the only predictor of further dissemination (P = .016). No significant tumor grade impact on LP or PLN was found. Our results indicate that NC differentiation in the primary tumor is a good predictor of lymph node dissemination.

Entities:  

Mesh:

Year:  2007        PMID: 17306328     DOI: 10.1016/j.humpath.2006.11.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

2.  Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder.

Authors:  Antonio Lopez Beltran; Liang Cheng; Rodolfo Montironi; Ana Blanca; Manuel Leva; Morgan Rouprêt; Jorge Fonseca; Alfredo Vidal; Carmen L Menendez; Judit Pallares; Enrico Bollito; Carlos Reymundo; Rafael J Luque; Eva Comperat
Journal:  Virchows Arch       Date:  2014-05-31       Impact factor: 4.064

3.  Prognostic significance of mucin expression in urothelial bladder cancer.

Authors:  Slavica Stojnev; Ana Ristic-Petrovic; Ljubinka Jankovic Velickovic; Miljan Krstic; Dragan Bogdanovic; Do Throng Khanh; Ana Ristic; Irena Conic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Is radical cystectomy mandatory in every patient with variant histology of bladder cancer.

Authors:  Nandakishore Kamalakar Shapur; Ran Katz; Dov Pode; Amos Shapiro; Vladimir Yutkin; Galina Pizov; Liat Appelbaum; Kevin C Zorn; Mordechai Duvdevani; Ezekiel H Landau; Ofer N Gofrit
Journal:  Rare Tumors       Date:  2011-04-04

5.  Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.

Authors:  Peng Ge; Zi-Cheng Wang; Xi Yu; Jian Lin; Qun He
Journal:  BMC Urol       Date:  2015-05-30       Impact factor: 2.264

6.  Expression of RCAS1 correlates with urothelial bladder cancer malignancy.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2015-02-10       Impact factor: 5.923

7.  Changes in Immunogenicity during the Development of Urinary Bladder Cancer: A Preliminary Study.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2016-02-25       Impact factor: 5.923

8.  The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer.

Authors:  Ofer N Gofrit; Vladimir Yutkin; Amos Shapiro; Galina Pizov; Kevin C Zorn; Guy Hidas; Ilan Gielchinsky; Mordechai Duvdevani; Ezekiel H Landau; Dov Pode
Journal:  Front Oncol       Date:  2016-03-15       Impact factor: 6.244

9.  Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Oncotarget       Date:  2016-03-08

10.  Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.